通过GABABR变异的阳性全调制逆转了预突触过敏性
Marielle Minere1, Martin Mortensen1, Valentina Dorovykh1
1Department of Neuroscience, Physiology and Pharmacology, University College London, London WC1E 6BT, UK.
Brain : a journal of neurology
|July 19, 2024
概括
三种GABBR2基因变异通过损害GABAB受体细胞表面表达导致严重的神经发育障碍. 阳性全调节可以逆转缺陷,为这些疾病提供治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- GABA-B受体 (GABABRs) 对于调节神经系统刺激性至关重要.
- GABABRs是G蛋白结合受体,由GABA激活,GABA是主要的抑制性神经递质.
- 最近发现了三种与严重神经发育障碍相关的GABBR2变异 (G693W,S695I,I705N).
研究的目的:
- 研究GABBR2变种的生物物理,分子贩运和功能后果.
- 阐明由这些GABABR变体引起的神经发育障碍背后的致病机制.
- 探索治疗策略,以纠正由GABBR2突变引起的缺陷.
主要方法:
- 混焦成像,流细胞计,结构建模和生物化学.
- 活细胞Ca2+成像,HEK-293 T细胞和神经元中的全细胞电生理学.
- 在Xenopus卵细胞中两电极电压紧.
主要成果:
- 这三种GABBR2变体都显著损害了GABABRs的神经元细胞表面表达,降低了信号的有效性.
- 一种变体通过增加突触前Ca2+信号,特别扰乱了神经传递.
- 阳性全调节有效地扭转了观察到的缺陷.
结论:
- GABBR2变种破坏GABABR功能,导致神经发育性疾病.
- 研究神经系统组织中的神经受体对于理解病变发生至关重要.
- 与GABABR相关的神经发育障碍的Allosteric调制是一种有前途的治疗方法.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
162
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
162
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
375
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
375
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
279
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
279
01:14Antiepileptic Drugs: Glutamate Antagonists
311
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
311
01:29Excitatory and Inhibitory Effects of Neurotransmitters
9.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.9K